Search results
Author(s):
Felix Mahfoud
,
Stefan Stortecky
,
Jay Giri
,
et al
Start date:
Dec 03, 2024
Join us for an insightful webinar designed to enhance an understanding of the latest developments in pulmonary embolism (PE) management.Moderated by Prof Felix Mahfoud (University Hospital Basel, CH), the faculty will explore current guidelines with a critical eye, particularly where gaps may exist, such as in managing intermediate-risk patients. Featuring findings from the PEERLESS study, this…
View more
Author(s):
Harriette Van Spall
,
Rajesh Kharbanda
Added:
7 months ago
ACC 25 - PROTECT-TAVI shows no benefit to routine use of cerebral embolic protection during transcatheter aortic valve implantation (TAVI).Dr Harriette Van Spall (McMaster University, CA) is joined by Prof Rajesh Kharbanda (Oxford University Hospitals NHS Foundation Trust, UK) to discuss the findings from the British Heart Foundation's PROTECT-TAVI Trial, which aimed to determine whether using…
View more
Author(s):
Dr Wissam A Jaber
Added:
1 year ago
TCT Conference 24 - PEERLESS II shows benefit of large-bore mechanical thrombectomy compared to catheter-directed thrombolysis for intermediate-risk pulmonary embolism (PE) patients.Dr Wissam A Jaber (Emory University Hospital Midtown, US) joins us onsite at TCT Conference to discuss the findings from PEERLESS (NCT06055920; Inari Medical).PEERLESS is a prospective, multicenter, randomized…
View more
Author(s):
Kengo Kusano
Added:
1 year ago
ACC.24 — We are joined by Dr Kengo Kusano (National Cerebral and Cardiovascular Center, JP) to discuss the findings from the Embo-Abl Study.Embo-Abl is a multicenter prospective randomized study which aims to compare the incidence of periprocedural cerebral embolisms caused by catheter ablation of atrial fibrillation (AF) between cryoballoon and radiofrequency ablation. 230 patients with AF from…
View more
Author(s):
William McIntyre
Added:
1 year ago
EHRA 24 - Investigator, Dr William McIntyre (Population Health Research Institute, CA) joins us to discuss the findings from a substudy of ARTESiA (NCT01938248).ARTESiA was a randomized, parallel assignment clinical trial which aimed to assess if apixaban could reduce the risk of ischemic stroke and systemic embolism in patients with subclinical atrial fibrillation (AF) and additional risk…
View more
Inverted Tulip Deformation
Author(s):
Kevin Velarde-Acosta
,
Josh Yefry Moscoso Ramirez
,
Paol Jhullian Rojas
,
et al
Added:
4 months ago
Article
AHA 25: The OCEAN Trial
Author(s):
Atul Verma
Added:
3 weeks ago
Video
Author(s):
Dee Dee Wang
Added:
3 months ago
Navigate the complexities of patient-prosthesis mismatch (PPM) in transcatheter aortic valve replacement with Dr Dee Dee Wang, exploring the critical distinctions that will shape 2025 clinical practice.This comprehensive presentation dissects the three distinct types of PPM, moving beyond traditional definitions to examine the real-world challenges facing interventional cardiologists today. Dr…
View more
Author(s):
Nazli Okumus
,
Ashley Park
,
Eugene Yuridistky
,
et al
Added:
1 year ago
José M Montero-Cabezas
Job title: Interventional Cardiologist
Author